title: Impact of orally disintegrating olanzapine on use of intramuscular antipsychotics, seclusion, and restraint in an acute inpatient psychiatric setting.
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Simpson
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Thompson
authors.forename: Mace
authors.initials: M
authors.lastname: Beckson
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D011595:Psychomotor Agitation; D011618:Psychotic Disorders / Q000188:drug therapy*; D012149:Restraint, Physical
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine